The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 14, 2023

Filed:

Jun. 21, 2019
Applicant:

Csp Advanced Solutions Inc., Abiko, JP;

Inventors:

Masahiko Kobayashi, Aichi, JP;

Masayuki Takasu, Abiko, JP;

Akira Mizuno, Nagoya, JP;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 41/00 (2020.01); A61K 41/10 (2020.01); A61F 9/00 (2006.01); H05H 1/24 (2006.01); A61K 47/02 (2006.01); A61K 9/08 (2006.01); A61P 27/02 (2006.01); A61K 47/36 (2006.01); H05H 1/48 (2006.01); H05B 41/24 (2006.01);
U.S. Cl.
CPC ...
A61K 41/10 (2020.01); A61F 9/0008 (2013.01); A61F 9/0026 (2013.01); A61K 9/08 (2013.01); A61K 41/00 (2013.01); A61K 47/02 (2013.01); A61K 47/36 (2013.01); A61P 27/02 (2018.01); H05B 41/24 (2013.01); H05H 1/24 (2013.01); H05H 1/2406 (2013.01); H05H 1/48 (2013.01); H05H 1/481 (2021.05);
Abstract

A plasma activated ophthalmic solution generating device operable to generate a therapeutic ophthalmic solution for curing epidemic keratoconjunctivitis includes a plasma generating electrode operable to generate a plasma activated ophthalmic solution for epidemic keratoconjunctivitis, wherein the plasma generating electrode is arranged surrounding an insert space where a unit dose ophthalmic eyedrop container with a container body, which seals a certain solution in a sterile state, is inserted; a power supply unit; and a high voltage generating unit, which is connected to the power supply unit, operable to be supplied with power source from the power supply unit and to apply high voltage electric current to the plasma generating electrode. This configuration makes it possible to provide a novel and effective therapeutic ophthalmic solution for epidemic keratoconjunctivitis (EKC).


Find Patent Forward Citations

Loading…